Janssen Inc. v. Abbvie Corporation, 2014 FCA 112 (Ustekinumab*)
Justice Stratas - 2014-05-01
Read full decision. Automatically generated summary:
Janssen Inc. moves for an order staying or suspending the remedies phase of a trial in the Federal Court. For the following reasons, I dismiss the motion with costs.
Circumstances may prompt Janssen to move again for a stay. Some or all of the evidence filed on this motion, and no doubt more, may be filed in that future stay motion. Also certain matters remain to be decided by the Federal Court.
Decision relates to:
- A-95-14 - JANSSEN INC. v. ABBVIE CORPORATION ET AL which is an appeal from 2014 FC 55 in T-1310-09